President Donald Trump announced on Wednesday that he has selected Dr. Heidi Overton to lead the Food and Drug Administration (FDA). Overton currently serves as a deputy assistant for domestic policy within the White House.

In a statement posted to Truth Social, President Trump praised Overton’s performance within his administration, describing her as a "rockstar" and stating that she would prioritize an "America First" agenda in her new role. While the announcement confirms the nomination, the two outlets provided offer differing levels of detail regarding her background and the administration's stated goals for the agency. Fox News highlights Overton’s professional background as a physician and notes her public stance on pro-life issues, framing the appointment as a continuation of the administration's domestic policy objectives. The Independent provides a more concise report, focusing primarily on her current role as a top White House aide without detailing her policy positions or the president's specific rhetoric regarding the nomination.

As the nomination process moves forward, the FDA commissioner will be responsible for overseeing the regulation of food, drugs, and medical devices in the United States. The confirmation process will likely involve a review of Overton's medical and policy experience by the Senate. Further details regarding her specific policy priorities for the agency are expected to emerge as the confirmation proceedings begin.